ORAL TREATMENT WITH NICORANDIL AT DISCHARGE IS ASSOCIATED WITH REDUCED MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION
Background. Previous studies showed that nicorandil can reduce coronary events in patients with coronary artery disease. However, it is unclear whether oral nicorandil treatment may reduce mortality following acute myocardial infarction (AMI). Methods and Results. We examined the impact of oral nico...
Saved in:
Main Authors: | Y. Sakata, D. Nakatani, M. Shimizu, Sh. Suna, M. Usami, S. Matsumoto, M. Hara, S. Sumitsuji, Sh. Kawano, K. Iwakura, T. Hamasaki, H. Sato, Sh. Nanto, M. Hori, I. Komuro |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2012-10-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1288 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01) -
MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01) -
PHARMACOLOGICAL PRECONDITIONING. FOCUS ON NICORANDIL
by: R. V. Gostishchev, et al.
Published: (2017-10-01) -
The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study)
by: Yu. V. Lukina, et al.
Published: (2022-09-01) -
ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)